Mather Group, Llc. 10x Genomics, Inc. Transaction History

Mather Group, Llc.

$8.17 Billion
Q2 2024

A detailed history of Mather Group, Llc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 4 shares of TXG stock, worth $90. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$90

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	BUY	$19.45 - $37.37 $77 - $149	4 New	4 $0
Q3 2021 Nov 04, 2021	SELL	$145.58 - $192.14 $2.45 Million - $3.24 Million	-16,842 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$134.22 - $202.37 $537,148 - $809,884	-4,002 Reduced 19.2%	16,842 $3.3 Million
Q1 2021 May 14, 2021	BUY	$140.25 - $196.86 $1.44 Million - $2.03 Million	10,291 Added 97.52%	20,844 $3.77 Million
Q4 2020 Feb 12, 2021	SELL	$126.47 - $163.7 $2.19 Million - $2.83 Million	-17,313 Reduced 62.13%	10,553 $1.49 Million
Q3 2020 Nov 13, 2020	SELL	$87.44 - $125.0 $28,505 - $40,750	-326 Reduced 1.16%	27,866 $3.47 Million
Q2 2020 Aug 14, 2020	SELL	$58.39 - $89.31 $379,885 - $581,050	-6,506 Reduced 18.75%	28,192 $2.52 Million
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $1.79 Million - $3.7 Million	34,698 New	34,698 $2.16 Million

Others Institutions Holding TXG

# of Institutions

284

Shares Held

96.2M

Call Options Held

162K

Put Options Held

107K

Vanguard Group Inc Valley Forge, PA

10.2M
Shares

$231 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

9.31M
Shares

$211 Million
1.65% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$145 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

6.15M
Shares

$139 Million
1.4% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

6.14M
Shares

$139 Million
0.09% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $2.15B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account